Literature DB >> 8856111

Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases.

A Braun1, S Kammerer, E Maier, E Böhme, A A Roscher.   

Abstract

The B2-bradykinin receptor gene has been proposed as one of the candidate genes involved in the complex genetic underpinnings of common chronic disorders such as hypertension, ischemic heart disease or allergic asthma. Suitable genetic markers are needed to study these hypotheses. Therefore, it was our aim to identify polymorphic sites in the B2-receptor gene. Up to now, we characterized four polymorphisms: one in the promoter region and three other ones in each of the exons. Possible biological consequences are delineated and preliminary results of allele specific different biological action are shown.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856111     DOI: 10.1016/0162-3109(96)00079-3

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  22 in total

Review 1.  Genes and human elite athletic performance.

Authors:  Daniel G Macarthur; Kathryn N North
Journal:  Hum Genet       Date:  2005-02-22       Impact factor: 4.132

Review 2.  Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia.

Authors:  G Onder; C Della Vedova; F Landi
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

3.  Angiotensin-converting enzyme and bradykinin gene polymorphisms and cough: A meta-analysis.

Authors:  Kazuaki Nishio; Shinji Kashiki; Hideaki Tachibana; Youichi Kobayashi
Journal:  World J Cardiol       Date:  2011-10-26

4.  Association of the human bradykinin B2 receptor gene with chronic renal failure.

Authors:  Lucyna Jozwiak; Andrzej Drop; Kinga Buraczynska; Piotr Ksiazek; Piotr Mierzicki; Monika Buraczynska
Journal:  Mol Diagn       Date:  2004

5.  eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril.

Authors:  P S Silva; V Fontana; M R Luizon; R Lacchini; W A Silva; C Biagi; J E Tanus-Santos
Journal:  Eur J Clin Pharmacol       Date:  2012-06-17       Impact factor: 2.953

Review 6.  Angiotensin antagonism in coronary artery disease: results after coronary revascularisation.

Authors:  Flavio Ribichini; Valeria Ferrero; Andrea Rognoni; Giovanni Vacca; Corrado Vassanelli
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema.

Authors:  Murat Bas; Thomas K Hoffmann; Bernd Tiemann; Vu Thao-Vi Dao; Christos Bantis; Vera Balz; Hans-Jürgen Schultz-Coulon; Thomas Stark; Patrick Schuler; Jens Greve; Katrin Ivens; Henning Bier; Georg Kojda
Journal:  Br J Clin Pharmacol       Date:  2010-02       Impact factor: 4.335

8.  BDKRB2 +9/-9 bp polymorphisms influence BDKRB2 expression levels and NO production in knee osteoarthritis.

Authors:  Shuo Chen; Lei Zhang; Ruonan Xu; Yunfan Ti; Yunlong Zhao; Liwu Zhou; Jianning Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-24

9.  Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.

Authors:  Gary P Van Guilder; Mias Pretorius; James M Luther; J Brian Byrd; Kevin Hill; James V Gainer; Nancy J Brown
Journal:  Hypertension       Date:  2008-01-07       Impact factor: 10.190

10.  TRPV1 and BDKRB2 receptor polymorphisms can influence the exercise pressor reflex.

Authors:  Karambir Notay; Shannon L Klingel; Jordan B Lee; Connor J Doherty; Jeremy D Seed; Michal Swiatczak; David M Mutch; Philip J Millar
Journal:  J Physiol       Date:  2018-09-19       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.